IL10 and neoplasm: Concurrently, IL‐10 activates exhausted CD8+ T cells (tumor‐resident memory‐like, CD62L−CD69+), boosting IFN‐γ production and cytotoxicity, which contributes to tumor elimination, recurrence prevention, and metastasis inhibition.